06/02/2026
Why is federal approval for psych*del!c medicine taking so long? 🏛️⚖️
One of the defining tensions in the U.S. is that while federal approval pathways can take years to unfold, people are in need of support now.
In this episode, Joshua Kappel () explores how policy, alongside research, shapes who gets access to care and when. We dive into:
🪐 The Federal Bottleneck: Why moving substances like MDM@ through traditional pharmaceutical pathways is often a years-long process.
🪐 State-Level Action: How states are creating new models for access while federal systems continue to evolve.
🪐 Legal Protections: The role of the Religious Freedom Restoration Act in protecting psych*del!c churches.
As interest in psych*del!c care continues to grow, so do the questions around access, regulation, and responsibility. We explore all of this and more in our conversation with Joshua.
Comment below and we’ll DM you the full episode link 👇
—
Disclaimer: Into the Multiverse does not provide medical or legal advice. ITM’s content is never intended as an attempt to buy, sell, trade, donate, gift, or ask for entheogens. ITM does not encourage illegal activity. Content posted here follows Meta’s Community Standards.